4D Molecular Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FDMT research report →
About the company
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology. The company's developmental efforts are concentrated across a trio of therapeutic fields: ophthalmology (eye conditions), cardiology (heart ailments), and pulmonology (respiratory disorders).
- CEO
- David H. Kirn
- IPO
- 2020
- Employees
- 227
- HQ
- EmeryVille, CA, US
Price Chart
- Market Cap
- $679.59M
- P/E
- -4.89
- P/S
- 7.70
- P/B
- 1.96
- EV/EBITDA
- -3.84
- Div Yield
- 0.00%
- Gross Margin
- -12.45%
- Op Margin
- -203.47%
- Net Margin
- -182.34%
- ROE
- -36.83%
- ROIC
- -37.80%
- Revenue
- $85.21M · 230194.59%
- Net Income
- $-140,109,000 · 12.90%
- EPS
- $-2.42 · 18.79%
- Op Income
- $-159,547,000
- FCF YoY
- 21.17%
- 52W High
- $14.00
- 52W Low
- $3.86
- 50D MA
- $9.81
- 200D MA
- $9.47
- Beta
- 2.69
- Avg Volume
- 864.79K
Get TickerSpark's AI analysis on FDMT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Bizily Scott | other | 814 |
| Jun 30, 26 | Bizily Scott | other | 5,752 |
| Jun 30, 26 | Bizily Scott | other | 814 |
| Jun 30, 26 | Bizily Scott | sell | 6,566 |
| Jun 30, 26 | Bizily Scott | other | 5,752 |
| Jun 23, 26 | Bizily Scott | other | 9,810 |
| Jun 23, 26 | Bizily Scott | other | 9,810 |
| Jun 23, 26 | Bizily Scott | sell | 9,810 |
| Jun 22, 26 | Kirn David | sell | 114,746 |
| Jun 17, 26 | Tomasello Shawn | other | 50,000 |
Our FDMT coverage
Recent articles, reports, and earnings notes.
No research on FDMT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FDMT report →Similar companies
Peers in the same neighborhood.